Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1991 Mar;46(3):205–207. doi: 10.1136/thx.46.3.205

Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for rheumatoid arthritis.

A Wollner 1, J Mohle-Boetani 1, R E Lambert 1, J L Perruquet 1, T A Raffin 1, J L McGuire 1
PMCID: PMC463037  PMID: 2028435

Abstract

Low dose methotrexate has been used effectively for various rheumatic and non-rheumatic diseases. Three cases of Pneumocystis carinii pneumonia occurring during treatment of rheumatoid arthritis with low dose methotrexate are presented. Several mechanisms might contribute to impaired immunity and the rare development of opportunist lung infection with methotrexate. A high degree of suspicion may result in earlier diagnosis and treatment.

Full text

PDF
207

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson L. L., Collins G. J., Ojima Y., Sullivan R. D. A study of the distribution of methotrexate in human tissues and tumors. Cancer Res. 1970 May;30(5):1344–1348. [PubMed] [Google Scholar]
  2. Groff G. D., Shenberger K. N., Wilke W. S., Taylor T. H. Low dose oral methotrexate in rheumatoid arthritis: an uncontrolled trial and review of the literature. Semin Arthritis Rheum. 1983 May;12(4):333–347. doi: 10.1016/0049-0172(83)90014-8. [DOI] [PubMed] [Google Scholar]
  3. Hellmann D. B., Petri M., Whiting-O'Keefe Q. Fatal infections in systemic lupus erythematosus: the role of opportunistic organisms. Medicine (Baltimore) 1987 Sep;66(5):341–348. doi: 10.1097/00005792-198709000-00002. [DOI] [PubMed] [Google Scholar]
  4. Leff R. L., Case J. P. Rheumatoid arthritis, methotrexate therapy, and Pneumocystis pneumonia. Ann Intern Med. 1990 May 1;112(9):716–716. doi: 10.7326/0003-4819-112-9-716_1. [DOI] [PubMed] [Google Scholar]
  5. Methotrexate in rheumatoid arthritis. Health and Public Policy Committee, American College of Physicians. Ann Intern Med. 1987 Sep;107(3):418–419. [PubMed] [Google Scholar]
  6. Morgan S. L., Baggott J. E., Altz-Smith M. Folate status of rheumatoid arthritis patients receiving long-term, low-dose methotrexate therapy. Arthritis Rheum. 1987 Dec;30(12):1348–1356. doi: 10.1002/art.1780301205. [DOI] [PubMed] [Google Scholar]
  7. Mullarkey M. F., Blumenstein B. A., Andrade W. P., Bailey G. A., Olason I., Wetzel C. E. Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N Engl J Med. 1988 Mar 10;318(10):603–607. doi: 10.1056/NEJM198803103181004. [DOI] [PubMed] [Google Scholar]
  8. Noble W. C., White P. M., Baker H. Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis. J Invest Dermatol. 1975 Feb;64(2):69–76. doi: 10.1111/1523-1747.ep12510255. [DOI] [PubMed] [Google Scholar]
  9. Olsen N. J., Callahan L. F., Pincus T. Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum. 1987 May;30(5):481–488. doi: 10.1002/art.1780300501. [DOI] [PubMed] [Google Scholar]
  10. Perruquet J. L., Harrington T. M., Davis D. E. Pneumocystis carinii pneumonia following methotrexate therapy for rheumatoid arthritis. Arthritis Rheum. 1983 Oct;26(10):1291–1292. doi: 10.1002/art.1780261021. [DOI] [PubMed] [Google Scholar]
  11. Wallis P. J., Ryatt K. S., Constable T. J. Pneumocystis carinii pneumonia complicating low dose methotrexate treatment for psoriatic arthropathy. Ann Rheum Dis. 1989 Mar;48(3):247–249. doi: 10.1136/ard.48.3.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Wilson W. R., Cockerill F. R., 3rd, Rosenow E. C., 3rd Pulmonary disease in the immunocompromised host (2). Mayo Clin Proc. 1985 Sep;60(9):610–631. doi: 10.1016/s0025-6196(12)60985-9. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES